Study guide

Physiology And Pathophysiology

ASCP MLS Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Orientation To ASCP MLS Certification

Credential Purpose And Role ASCP BOC And Eligibility At A High Level MLS Versus MLS(ASCPi) Wording Application Fee And Transcript Result Basics CAT Exam Model Overview Study Plan From Content Guideline

2 Exam Format, CAT Scoring, And Score details

100 Questions And 2h30m Computer Adaptive Testing One-Best-Answer Multiple Choice Theoretical Versus Procedural Questions Scaled Score 100-999, Minimum 400 Score Notification Timing And Transcript Dependency

3 Blood Banking

Products And Components Blood Group Systems And Immunology Serologic And Molecular Testing Compatibility Testing And Transfusion Practice Physiology And Pathophysiology High-Yield Study Strategy

4 Chemistry

Carbohydrates, Lipids, Proteins, And Nitrogen Compounds Enzymes And Heme Derivatives Acid-Base, Blood Gases, And Electrolytes Endocrinology, Vitamins, And Nutrition Therapeutic Drug Monitoring And Toxicology Calculations And Correlation

5 Hematology And Hemostasis

Normal Hematopoiesis And Cell Morphology Anemia And RBC Disorders Leukocyte Disorders And Disease States Platelet And Coagulation Physiology Hemostasis Testing Smear, Analyzer, And Result Correlation

6 Microbiology

Preanalytic Specimen Handling Bacteriology Analytic Procedures Susceptibility And Organism Identification Logic Mycobacteriology, Virology, Parasitology, And Mycology Postanalytic Reporting Safety And Contamination Awareness

7 Urinalysis And Other Body Fluids

Physical And Chemical Urinalysis Microscopic Sediment Renal Physiology And Disease States CSF And Serous Fluids Body Fluid Cell Counts And Crystals Correlation And Preanalytic Issues

8 Immunology

Principles Of Immune Response Immune-System Diseases Infectious Disease Serology Transplantation And Compatibility Concepts Serologic Procedures And Test Methodology Interpretation Pitfalls

9 Laboratory Operations

Quality Assessment And Troubleshooting Safety Laboratory Mathematics Manual And Automated Methodology Instrumentation And Validation Management And Education Principles

10 Integrated Case Reasoning And Calculations

Correlating Patient Results To Disease States Applying Knowledge To New Facts Calculations And Units Procedural Decision-Making QA/QC In Case Questions Avoiding Memorization-Only Study

11 Practice Strategy And Remediation

Content Percentage Allocation CAT-Aware Practice Mindset Reviewing Misses By Domain Using The Official Guideline Before Third-Party Materials Transcript And Result Timing In Planning Final Remediation Cycles

12 Final Review And Exam-Day Readiness

Final-Week Schedule Timing And Pacing Score Expectations Result And Credential Next Steps Digital Badge And Documentation Post-Exam Actions Without Promises

Physiology And Pathophysiology

Key Takeaways Explain This Topic AI

Hemolytic disease of the fetus and newborn is most severe with anti-D and anti-Kell; Rh immune globulin prevents D alloimmunization.

A standard 300 ug RhIG dose covers 15 mL of D-positive fetal cells (30 mL whole blood); the rosette test screens and Kleihauer-Betke quantifies the bleed.

Warm autoimmune hemolytic anemia is IgG-mediated and reacts at 37 C; cold agglutinin disease is IgM/C3d-mediated and reacts in the cold.

Autoadsorption, eluate, and antigen-typing techniques separate autoantibody from masked underlying alloantibodies.

Last updated: June 2026

Hemolytic disease of the fetus and newborn (HDFN)

HDFN occurs when maternal IgG antibody crosses the placenta and destroys fetal red cells bearing the corresponding paternally inherited antigen. Because only IgG crosses, ABO HDFN (anti-A,B from group O mothers) is common but usually mild , while anti-D and anti-Kell cause the most severe disease. Anti-Kell is distinctive: it not only hemolyzes cells but suppresses erythroid precursors in the marrow , so the bilirubin and reticulocyte response can underestimate severity.

Laboratory correlation: a positive DAT on cord blood , rising bilirubin, anemia, and a maternal IgG antibody identified by IAT confirm HDFN. The newborn workup includes ABO/Rh, DAT, and an eluate to identify the coating antibody.

Rh immune globulin and fetomaternal hemorrhage

Rh immune globulin (RhIG) is passive anti-D given to D-negative mothers to prevent active anti-D formation. The standard antepartum (28 weeks) and postpartum dose is 300 ug , which neutralizes 15 mL of D-positive fetal red cells (30 mL of fetal whole blood) . Workup of a possible large bleed:

Rosette test — qualitative screen for fetomaternal hemorrhage; if negative, one vial covers it.

Kleihauer-Betke (acid elution) or flow cytometry — quantifies fetal cells when the rosette is positive.

Dose calculation : vials = (% fetal cells x 5000 mL maternal volume) / 30 mL per vial. Round up , then add one vial as a safety margin.

Worked example: a Kleihauer-Betke shows 1.2% fetal cells. Fetal bleed = 0.012 x 5000 = 60 mL. Vials = 60 / 30 = 2.0; round to 2, add 1 = 3 vials of RhIG . This calculation is a recurring MLS computation.

Autoimmune hemolytic anemias

The warm-versus-cold distinction drives the workup and is one of the most reliable theoretical-correlation items.

  • Feature Warm AIHA Cold agglutinin disease
  • Antibody class IgG IgM
  • Optimal temperature 37 C 4 C (reacts in cold)
  • DAT pattern Anti-IgG (+/- C3d) Anti-C3d (IgM elutes off)
  • Typical specificity Broad / Rh-related Anti-I (anti-i in mono)
  • Associations Lymphoma, lupus, drugs Mycoplasma, mononucleosis
  • Sample handling Standard Keep warm at 37 C
  • Resolving autoantibodies that mask alloantibodies

A strong autoantibody can react with all panel cells , hiding an underlying alloantibody that could cause a transfusion reaction. Techniques to unmask it:

Warm autoadsorption removes autoantibody using the patient's own enzyme-treated cells (only valid if not transfused in the last 3 months , otherwise donor cells confound it).

Allogeneic/differential adsorption uses reagent cells of selected phenotypes for recently transfused patients.

Eluate recovers and identifies antibody bound to the patient's cells.

Prewarm technique and cold autoadsorption neutralize cold autoantibodies so a 37 C-reactive alloantibody can be detected.

Drug-induced hemolysis and elution logic

Drug-induced immune hemolytic anemia produces a positive DAT through several mechanisms the exam contrasts: the drug-adsorption (hapten) type (classically high-dose penicillin) where antibody reacts only with drug-coated cells; the immune-complex type where the drug-antibody complex deposits and activates complement; and the autoantibody type (classically methyldopa, and many newer drugs) producing a true warm autoantibody indistinguishable from idiopathic warm AIHA. The workup adds drug-treated cells and drug in the test system to confirm specificity.

An eluate is the recovered antibody stripped from a patient's sensitized red cells, and its interpretation is diagnostic: in HDFN the eluate identifies the maternal antibody (e.g., anti-D), in a delayed hemolytic reaction it reveals the anamnestic alloantibody, and in warm AIHA it shows broad, panreactive IgG. Knowing what an eluate should contain in each scenario is a frequent correlation item.

Putting the correlation logic together

The exam's recurring physiology logic flows in four steps. First, identify the antibody's class and thermal range from the serologic data. Second, predict the disease — IgG crossing the placenta points to HDFN, 37 C-reactive IgG with an anti-IgG DAT points to warm AIHA, and cold IgM with a C3d-only DAT points to cold agglutinin disease. Third, compute RhIG when a D-negative mother has a measured fetomaternal bleed, remembering the round-up-then-add-one convention.

Fourth, select the adsorption or elution method that exposes a clinically significant alloantibody hidden beneath an autoantibody, mindful that recent transfusion forbids warm autoadsorption and mandates differential allogeneic adsorption. Mastering this chain — from a positive DAT through monospecific reagents, eluate, and adsorption to a transfusion decision — is what separates a passing Blood Banking performance from rote memorization on the computer adaptive MLS exam.

Antenatal monitoring and prevention

Managing an alloimmunized pregnancy is a recurring correlation theme. Once a clinically significant maternal IgG antibody is identified, the lab follows a titer at intervals; a critical titer (commonly 16 or 32 for anti-D) prompts referral for fetal monitoring such as middle cerebral artery Doppler. Prevention remains the priority: routine antepartum RhIG at 28 weeks and again postpartum within 72 hours for D-negative mothers carrying or delivering a D-positive infant, plus extra doses after amniocentesis, abortion, or trauma.

A positive postpartum maternal antibody screen showing passive anti-D from RhIG must be distinguished from active immunization, because the management diverges sharply. Tying titer trends, RhIG timing, and the fetal-bleed quantitation together is the kind of multistep reasoning the MLS exam favors.